This review summarizes the organization and structure of vagal neurocircuits controlling the upper gastrointestinal tract, and more recent studies investigating their role in the regulation of gastric motility under physiological, as well as pathophysiological, conditions.
INTRODUCTION
Langley [1] described the enteric nervous system (ENS) as a third branch of the autonomic nervous system confirming that the stomach and gastrointestinal tract can function largely independently from central nervous system (CNS) control. Although the ENS is certainly a highly complex neural network that endows the gastrointestinal tract with sophisticated reflexes and elaborate intrinsic control, it is also clear that the extrinsic innervation to the gastrointestinal tract, arising from both the sympathetic and parasympathetic branches of the autonomic nervous system, provides important integration, regulation, modulation, and coordination of gastrointestinal functions. This review will describe the basic neurocircuitry of extrinsic, principally parasympathetic, inputs to the gastrointestinal tract, as well as the role of the CNS in regulation of the physiology and pathophysiology of gastrointestinal motility.
SYMPATHETIC CONTROL OF THE GASTROINTESTINAL TRACT
Sympathetic innervation to the gastrointestinal tract arise from the intermediolateral column of the thoracolumbar spinal cord [2] and provide a principally inhibitory input to gastrointestinal smooth muscle, a tonic inhibitory influence over mucosal secretion, and regulation of blood flow throughout the gastrointestinal tract, via neurally dependent vasoconstriction. Sympathetic inputs can modulate motility mostly via indirect, presynaptic modulation of neurotransmitter release; sympathetic regulation of motility, however, appears limited, at least when compared to the extensive control exerted by the parasympathetic nervous system. tract are provided by the vagus (Xth cranial) nerve, the efferent (motor) cell bodies of which are located within the dorsal motor nucleus of the vagus (DMV) within the hindbrain. The efferent projections of these motoneurons form distinct vagal branches which have discrete subdiaphragmatic innervation patterns [3] [4] [5] and DMV neurons can be subdivided into distinct subgroups, based upon their morphological, biophysical, and functional properties as well as their visceral target organ [6] .
Several studies, both in vivo and in vitro, have shown that DMV neurons regulating gastric functions are tonically active and exhibit 'pacemaker' properties, firing action potentials at a regular rate of around 1 Hz [7, 8] . In part, this is due the intrinsic biophysical properties of these neurons, but DMV neuronal activity is also controlled to a large degree by tonically active synaptic inputs, particularly from the adjacent nucleus tractus solitarius (NTS). Both in-vivo and in-vitro neurophysiological studies have shown that although DMV neurons also receive catecholaminergic and excitatory glutamatergic inputs, under basal conditions, it is the ongoing, tonic gamma amino butyric acid (GABAergic) inhibitory synaptic input that plays the most significant role in regulating DMV neuronal activity [8] [9] [10] [11] . Modulation of these critically important GABAergic synaptic inputs, therefore, has the potential to exert profound effects upon DMV neuronal excitability, and vagal efferent control of gastric motility. NTS neurons are themselves the recipient of afferent (sensory) vagal inputs from thoracic and subdiaphragmatic organs [12, 13] . Together with the area postrema, the NTS and DMV collectively form the dorsal vagal complex (DVC), the locus for central control of gastric functions, including motility.
PHYSIOLOGY AND PATHOPHYSIOLOGY OF CENTRAL MODULATION OF GASTRIC FUNCTIONS
It is well recognized that gastrointestinal neurohormones, released from enteroendocrine cells lining the gastrointestinal tract, exert paracrine actions on peripheral vagal afferent terminals to modulate vagally dependent gastric functions. Cholecystokinin (CCK), serotonin, and glucagon-like peptide 1 (GLP-1) released from enteroendocrine cells following ingestion of nutrients activate vagal afferent terminals [14] [15] [16] ; the resulting excitatory signal is relayed centrally, activates NTS neurons, and induces reflexive gastric relaxation via either activation of the inhibitory non adrenergic non cholinergic pathway or inhibition and withdrawal of the tonically active cholinergic pathway [17] . Perhaps less well appreciated, but no less important, are the direct actions on central vagal neurocircuits that these circulating neuropeptides may also exert. As a circumventricular organ lying ventral to the fourth ventricle, the DVC is surrounded by fenestrated capillaries, Virchow-Robin perivascular spaces, and a loose blood brain barrier, allowing circulating neurohormones, neuropeptides, and neuromodulators much greater access to act directly on central vagal neurocircuits to alter their activity [18, 19] . Indeed, peripheral CCK has been shown to activate vagal neurocircuits directly, even in the absence of vagal afferents [20] .
Interestingly, the many of the same neuropeptides that activate peripheral vagal afferent terminals are also expressed by neurons within central vagal neurocircuits. For example, preproglucagonimmunoreactive (i.e., GLP-1 containing) neurons are located within the NTS and medullary reticular formation, and provide an extensive central network through which GLP-1 receptor signaling reduces food intake and modulates autonomic responsiveness [21] . It remains to be clarified, however, whether the central neurons modulated by circulating neurohormones directly are the same as those ones activated synaptically following paracrine actions of the same neurohormones at peripheral vagal afferent terminals. Notably, recent studies have demonstrated that preproglucagon-immunoreactive neurons do not express GLP-1 receptorimmunoreactive and do not respond directly to GLP-1 suggesting a potential disconnect between the neuropathways engaged by GLP-1 at the peripheral (vagal afferent) and central (NTS) levels [22] . It remains to be determined whether such an apparent
KEY POINTS
The parasympathetic nervous system provides both excitatory and inhibitory inputs to the stomach and small intestine allowing for precise, responsive, and discriminating control over gastrointestinal functions.
DMV neurons innervating the stomach are tonically active and provide a basal excitatory drive to the stomach via the efferent vagus nerve.
Central vagal neurocircuits controlling gastrointestinal functions are remarkably plastic and open to modulation from other brainstem, midbrain, and higher cortical centers.
The extensive connectivity of central vagal neurocircuits, and their prominent role in the integration of ascending (interoceptive) and descending (motor) outputs may provide a means by which gastrointestinal dysfunctions associated with neurological disorders can be explained.
disconnect is common to other central peptidergic systems within the CNS in general, or within central vagal neurocircuitry in particular.
Somewhat surprisingly, given the importance of GABAergic NTS-DMV synaptic transmission in regulating vagal efferent outflow to the stomach, this synapse is remarkably resistant to modulation, at least under basal in-vivo and in-vitro conditions. Work from our own laboratories have shown that the 'state of activation' of this critical inhibitory NTS-DMV synapse is determined by ongoing vagal afferent activity [23, 24] . Vagal afferents make monosynaptic connections with inhibitory NTS terminals [25] ; the tonic release of glutamate from vagal afferent terminals activates presynaptic group II metabotropic glutamate receptors, which are negatively coupled to adenylate cyclase. By reducing cAMP levels, hence PKA activation, many neurotransmitters/ modulators (e.g., serotonin [26] , m opioid receptors [27, 28] This becomes of physiological importance when one considers the myriad of potential endogenous activators of adenylate cyclase within these neurocircuits, including feeding neuropeptides like CCK and GLP-1, stress hormones such as corticotrophin releasing factor (CRF), endocrine hormones such as insulin, and -importantly -even vagal afferent activity itself. The degree of tonic synaptic inhibition of DMV neurons, and therefore vagal efferent activity to the upper gastrointestinal tract, appears to be remarkably labile and exquisitely responsive to ongoing physiological conditions. Indeed, a series of recent elegant studies have shown that, in rodents, the mechanosensitivity of vagal afferents, that is, their ability to respond to gastric stretch and distention hence appropriately regulate food intake and satiation, is subject to diurnal rhythms. The sensitivity of gastric vagal afferents is lowest during the dark cycle, for example, and is associated with increased food intake in line with energy demand [33] . Exposure to a high-fat diet (HFD) ablates this circadian rhythmicity resulting in increased food intake during the light cycle, contributing to the development of obesity [34 && ]. Time-restricted feeding, however, prevented the HFD-induced loss of circadian rhythmicity suggesting that vagal afferent sensitivity may be entrained not only by nutrient content, but by the timing of food intake [35 & ]. The capacity of time-restricted feeding regimens to prevent diet-induced loss of normal vagal circadian rhythmicity, and potentially restore appropriate vagal afferent and efferent functions, has potential important implications for the therapeutic treatment of obesity.
DIET-INDUCED MODULATION OF CENTRAL VAGAL NEUROCIRCUITS
The regulation of food intake and satiety is complex, involving both homeostatic and hedonic components [36] [37] [38] . Although the influence of vagal neurocircuits on the homeostatic regulation of feeding behavior is well recognized, less attention has been paid to the effects that HFD and DIO exert directly on gastricprojecting DMV neurons. Following HFD or DIO, DMV neurons are less excitable and less responsive to satiety neuropeptides [39, 40] , hence vagal efferent control of the upper gastrointestinal tract is reduced. Indeed, obesity is associated with dysregulated gastric motility, altered gastric emptying rates, and an increase in gastric volume, which appears to delay satiation by requiring a larger volume of food to be ingested before signaling fullness [41] [42] [43] . Even acute periods of HFD exposure (3-5 days) alter vagal neurocircuitry, however. Upon initial exposure to a HFD, caloric intake increases; within 3-5 days, however, homeostatic regulation reduces food intake to restore caloric balance. Recent studies have shown that this period of autonomic regulation is associated with, and potentially determined by, plasticity within central vagal neurocircuits. Under basal conditions, glutamatergic NTS-DMV synaptic transmission is mediated via a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-receptor signaling; following acute HFD exposure, however, excitatory NTS-DMV glutamatergic transmission is increased via the recruitment and activation of synaptic N-methyl-D-aspartate receptors which plays a significant role in determining DMV neuron excitability, preserving vagal efferent activity to the stomach, and the retention of appropriate gastric functions, including motility [44 && ]. Such rapid alterations in the central regulation of gastric functions provide further support for the concept for the homeostatic regulation of vagal neurocircuitry to maintain appropriate central control of gastric functions in the face of altered physiological demand or conditions.
EARLY LIFE EVENTS AND DEVELOPMENTAL MODULATION OF CENTRAL VAGAL NEUROCIRCUITS
As a general principle, during critical periods of neurodevelopment, the brain undergoes considerable synaptic plasticity, pruning, and circuit refinement, during which temporally regulated neurocircuit maturation and patterning occurs. Disruption to these critical developmental periods, either genetic, epigenetic, or environmental, may result in impaired neurocircuit 'hard-wiring' and altered output responses. From the standpoint of central control of gastrointestinal functions, descending preautonomic inputs from the hypothalamus, central nucleus of the amygdala, bed nucleus of the stria terminalis, and cortex reach the DVC in the first postnatal week and continue to mature into the second postnatal week [45] [46] [47] . Early life experience, therefore, has the potential to modulate neurocircuit development hence exert profound effects upon the predisposition to develop functional gastrointestinal disorders, including affecting visceral sensory responsiveness, and decreasing stress resilience and/or increasing stress susceptibility [48, 49] In rodent models, early life adverse events have been shown to modify the developmental assembly and maturation of autonomic homeostatic neurocircuits, including those within the hypothalamus and brainstem that regulate gastrointestinal functions. Repeated brief maternal separation during the early neonatal period, for example, decreases stress reactivity in adults, whereas more stressful early life events, such as prolonged maternal separation or neonatal limited nesting, increases stress reactivity and visceral hypersensitivity in adulthood. Such developmental manipulations were associated with a delay in the assembly of central visceral neurocircuits, particularly in the establishment and synaptic connectivity of descending 'preautonomic' inputs [50, 51] . Maternal diet can also exerts profound effects upon neurodevelopment [52] ; exposure to a maternal HFD, for example, increases the inhibition of gastric-projecting DMV neurons, decreasing their excitability, possibly contributing to the dysregulated vagal control of gastric functions. [53] , and also increases stress reactivity in adulthood [52, 54] .
STRESS AND MODULATION OF GASTRIC FUNCTIONS
Stress may be considered as a state of threatened homeostatic imbalance, caused either by intrinsic or extrinsic factors, that is counteracted by an array of autonomic and behavioral responses designed to reestablish equilibrium. Stress itself is neither deleterious nor harmful; rather, it is the inability to cope effectively with stress that is injurious and detrimental to health. Brief stressors may even be considered protective, allowing transient adaptation to internal or external threats, whereas prolonged stress represents a more serious challenge to ongoing homeostasis, requiring a more sustained engagement of both autonomic and behavioral neurocircuits to restore function. The lack of appropriate adaptation to prolonged stress can exert profound effects upon gastrointestinal functions, decreasing gastric emptying and increasing colonic motility [55] [56] [57] [58] [59] . In susceptible individuals, however, functional gastrointestinal disorders are correlated highly with stress, and stress aggravates and worsens gastrointestinal functions [60] [61] [62] . Although stress engages the hypothalamic-pituitary-adrenal axis to produce a concerted endocrine response, it also activates the brain-gut axis, and engages descending CRF, oxytocinergic, and catecholaminergic inputs which regulate and modulate vagal efferent projections to the gastrointestinal tract [61, 63, 64] . Indeed, recent several studies in rodents have shown that stress adaptability is associated with an upregulation of oxytocin and catecholaminergic inputs to the DVC [65, 66] which are essential for the restoration of gastrointestinal functions.
NEUROLOGICAL DISEASES AND CONTROL OF GASTROINTESTINAL FUNCTIONS
The dysregulation and dysfunction of gastrointestinal functions that occurs in response to neurological diseases has justifiably been the subject of increased attention from several laboratories. Gastrointestinal dysregulation is commonly associated with multiple sclerosis [67, 68] , autism [69, 70] , schizophrenia [71] , and Parkinson's disease [72, 73] , to name but a few CNS disorders, because of both central and peripheral dysfunction.
The gastrointestinal dysfunction in Parkinson's Disease has, perhaps, received the most concerted attention recently, although, having been described by James Parkinson in his original treatise on the disease, the involvement of the gastrointestinal tract in Parkinson's Disease is hardly novel. Dysphagia, sialorrhea, gastroparesis, and constipation affect a significant proportion of Parkinson's Disease patients; indeed, gastrointestinal dysfunctions are frequently prodromal to the well described motor symptoms, often occurring even decades before official diagnosis [74] . Recently, however, the description of a novel nigro-vagal neuropathway has demonstrated that a direct, monosynaptic connection exists between the substantia nigra pars compacta (SNpc) and the DVC, including neurons of the DMV, and exerts a tonic influence over gastric motility and tone. Optogenetic inhibition of these nigro-vagal nerve terminals within the DVC inhibits basal gastric tone and motility, and attenuates the increased motility and tone induced by stimulation of the SNpc [75 && ]. The finding of a direct descending connection between the SNpc and the DVC also provides strong support for the hypothesis first put forward by Braak et al. [76] [77] [78] that idiopathic Parkinson's Disease may result from ingestion of an environmental toxin which induces a distinct sequence of pathological and degenerative events, affecting the ENS first before traveling centrally in a retrograde fashion via the efferent vagus nerve to affect neurons of the DMV, and from thence ascending to affect the SNpc, via this newly described nigro-vagal pathway [75 && ]. More broadly speaking, however, the extensive connectivity of the DVC and its central role in the integration of ascending (interoceptive) inputs and descending (motor) outputs suggests a means by which gastrointestinal dysfunctions associated with other neurological disorders may be explained, investigated, and understood.
CONCLUSION
Although the central control of gastrointestinal functions, particularly vagal (parasympathetic) control of motility, is understood at a basic neurocircuit level, there is still much work to be done to understand the many and varied means by which the CNS is involved in gastrointestinal physiology, and pathophysiology. Work from several laboratories in recent years has highlighted not only the remarkable degree of plasticity within vagal neurocircuits controlling gastrointestinal motility, but also the importance of inputs from other brainstem, midbrain, and higher cortical centers in the regulation of vagal neuronal activity and efferent output. It is unsurprising, therefore, that gastrointestinal motility disturbances are common, often chronic and disabling, conditions. Increasing awareness of the pivotal role that the CNS plays in the gastrointestinal physiology and pathophysiology should serve to encourage and facilitate research into 'big brain' aspects of 'little brain' problems.
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